- Home
- RDAC vs XGN Comparison
RDAC vs XGN Comparison
Compare RDAC & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDAC
- XGN
- Stock Information
- Founded
- RDAC 2024
- XGN 2002
- Country
- RDAC China
- XGN United States
- Employees
- RDAC N/A
- XGN N/A
- Industry
- RDAC
- XGN Medical Specialities
- Sector
- RDAC
- XGN Health Care
- Exchange
- RDAC NYSE
- XGN Nasdaq
- Market Cap
- RDAC 75.2M
- XGN 86.6M
- IPO Year
- RDAC 2024
- XGN 2019
- Fundamental
- Price
- RDAC $10.10
- XGN $3.58
- Analyst Decision
- RDAC
- XGN Strong Buy
- Analyst Count
- RDAC 0
- XGN 2
- Target Price
- RDAC N/A
- XGN $7.50
- AVG Volume (30 Days)
- RDAC 457.0
- XGN 153.9K
- Earning Date
- RDAC 01-01-0001
- XGN 03-17-2025
- Dividend Yield
- RDAC N/A
- XGN N/A
- EPS Growth
- RDAC N/A
- XGN N/A
- EPS
- RDAC N/A
- XGN N/A
- Revenue
- RDAC N/A
- XGN $55,751,000.00
- Revenue This Year
- RDAC N/A
- XGN $7.13
- Revenue Next Year
- RDAC N/A
- XGN $19.14
- P/E Ratio
- RDAC N/A
- XGN N/A
- Revenue Growth
- RDAC N/A
- XGN 8.00
- 52 Week Low
- RDAC $9.98
- XGN $1.30
- 52 Week High
- RDAC $10.41
- XGN $6.22
- Technical
- Relative Strength Index (RSI)
- RDAC N/A
- XGN 38.58
- Support Level
- RDAC N/A
- XGN $3.63
- Resistance Level
- RDAC N/A
- XGN $4.55
- Average True Range (ATR)
- RDAC 0.00
- XGN 0.50
- MACD
- RDAC 0.00
- XGN -0.13
- Stochastic Oscillator
- RDAC 0.00
- XGN 2.75
About RDAC RISING DRAGON ACQUISITION CORP
Rising Dragon Acquisition Corp is a blank check company.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.